Literature DB >> 22623650

Chronic hepatitis C virus infection breaks tolerance and drives polyclonal expansion of autoreactive B cells.

Jill E Roughan1, Kathryn M Reardon, Kristin E Cogburn, Heribert Quendler, Paul J Pockros, Mansun Law.   

Abstract

Chronic Hepatitis C virus (HCV) infection has been linked with B cell lymphoproliferative disorders and several autoimmune-related diseases. The mechanisms of how chronic viral infection affects B cell development and predisposes the patients to autoimmune manifestations are poorly understood. In this study, we established an experimental system to probe the B cell responses and characterize the antibodies from chronic-HCV-infected individuals. We identified an unusual polyclonal expansion of the IgM memory B cell subset in some patients. This B cell subset is known to be tightly regulated, and autoreactive cells are eliminated by tolerance mechanisms. Genetic analysis of the immunoglobulin (Ig) heavy chain variable gene (V(H)) sequences of the expanded cell population showed that the levels of somatic hypermutation (SHM) correlate with the extent of cell expansion in the patients and that the V(H) genes exhibit signs of antigen-mediated selection. Functional analysis of the cloned B cell receptors demonstrated autoreactivity in some of the expanded IgM memory B cells in the patients which is not found in healthy donors. In summary, this study demonstrated that, in some patients, chronic HCV infection disrupts the tolerance mechanism that normally deletes autoreactive B cells, therefore increasing the risk of developing autoimmune antibodies. Long-term follow-up of this expanded B cell subset within the infected individuals will help determine whether these cells are predictors of more-serious clinical manifestations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22623650      PMCID: PMC3393369          DOI: 10.1128/CVI.00194-12

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  77 in total

Review 1.  V(D)J recombination.

Authors:  David G Schatz
Journal:  Immunol Rev       Date:  2004-08       Impact factor: 12.988

2.  Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset.

Authors:  Edgar D Charles; Claudia Brunetti; Svetlana Marukian; Kimberly D Ritola; Andrew H Talal; Kristen Marks; Ira M Jacobson; Charles M Rice; Lynn B Dustin
Journal:  Blood       Date:  2011-03-18       Impact factor: 22.113

Review 3.  Human B cell subsets.

Authors:  Stephen M Jackson; Patrick C Wilson; Judith A James; J Donald Capra
Journal:  Adv Immunol       Date:  2008       Impact factor: 3.543

4.  Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse.

Authors:  M J Shlomchik; A H Aucoin; D S Pisetsky; M G Weigert
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

5.  Antibody production and in vitro behavior of CD27-defined B-cell subsets: persistent hepatitis C virus infection changes the rules.

Authors:  Vito Racanelli; Maria Antonia Frassanito; Patrizia Leone; Maria Galiano; Valli De Re; Franco Silvestris; Franco Dammacco
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

6.  Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry).

Authors:  Manuel Ramos-Casals; Sandra Muñoz; Francisco Medina; Luis-Javier Jara; José Rosas; Jaime Calvo-Alen; Pilar Brito-Zerón; Xavier Forns; Jose-Maria Sánchez-Tapias
Journal:  J Rheumatol       Date:  2009-04-15       Impact factor: 4.666

7.  Clonal evolution of a follicular lymphoma: evidence for antigen selection.

Authors:  D W Bahler; R Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

Review 8.  Ectopic lymphoid tissues and local immunity.

Authors:  Damian M Carragher; Javier Rangel-Moreno; Troy D Randall
Journal:  Semin Immunol       Date:  2008-02-19       Impact factor: 11.130

9.  Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen.

Authors:  Stephanie Kruetzmann; M Manuela Rosado; Holger Weber; Ulrich Germing; Olivier Tournilhac; Hans-Hartmut Peter; Reinhard Berner; Anke Peters; Thomas Boehm; Alessandro Plebani; Isabella Quinti; Rita Carsetti
Journal:  J Exp Med       Date:  2003-04-07       Impact factor: 14.307

10.  In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. III. The kinetics of V region mutation and selection in germinal center B cells.

Authors:  J Jacob; J Przylepa; C Miller; G Kelsoe
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

View more
  10 in total

1.  T cell-dependent IgM memory B cells generated during bacterial infection are required for IgG responses to antigen challenge.

Authors:  Jennifer L Yates; Rachael Racine; Kevin M McBride; Gary M Winslow
Journal:  J Immunol       Date:  2013-06-26       Impact factor: 5.422

2.  Abnormal phenotypic features of IgM+B cell subsets in patients with chronic hepatitis C virus infection.

Authors:  Fanyun Kong; Bo Feng; Henghui Zhang; Huiying Rao; Jianghua Wang; Xu Cong; Lai Wei
Journal:  Exp Ther Med       Date:  2017-06-27       Impact factor: 2.447

3.  Type I interferon suppresses virus-specific B cell responses by modulating CD8+ T cell differentiation.

Authors:  E Ashley Moseman; Tuoqi Wu; Juan Carlos de la Torre; Pamela L Schwartzberg; Dorian B McGavern
Journal:  Sci Immunol       Date:  2016-10-21

Review 4.  Autoimmunity and infection in Sjögren's syndrome.

Authors:  Ann Igoe; R Hal Scofield
Journal:  Curr Opin Rheumatol       Date:  2013-07       Impact factor: 5.006

Review 5.  Immunity and hepatitis C: a review.

Authors:  Rebecca R Terilli; Andrea L Cox
Journal:  Curr HIV/AIDS Rep       Date:  2013-03       Impact factor: 5.071

6.  Pseudotyping retrovirus like particles vaccine candidates with Hepatitis C virus envelope protein E2 requires the cellular expression of CD81.

Authors:  Hugo R Soares; Rute Castro; Hélio A Tomás; Manuel J T Carrondo; Paula M Alves; Ana S Coroadinha
Journal:  AMB Express       Date:  2019-02-07       Impact factor: 3.298

7.  Genetic and structural insights into broad neutralization of hepatitis C virus by human VH1-69 antibodies.

Authors:  Netanel Tzarum; Erick Giang; Leopold Kong; Linling He; Jannick Prentoe; Elias Augestad; Yuanzi Hua; Shaun Castillo; Georg M Lauer; Jens Bukh; Jiang Zhu; Ian A Wilson; Mansun Law
Journal:  Sci Adv       Date:  2019-01-02       Impact factor: 14.136

Review 8.  Hepatitis C Virus Epitope Immunodominance and B Cell Repertoire Diversity.

Authors:  Nicholas A Brasher; Anurag Adhikari; Andrew R Lloyd; Nicodemus Tedla; Rowena A Bull
Journal:  Viruses       Date:  2021-05-25       Impact factor: 5.048

9.  Hepatitis C virus infection and autoimmune diseases.

Authors:  Marino Paroli; Gino Iannucci; Daniele Accapezzato
Journal:  Int J Gen Med       Date:  2012-10-23

Review 10.  Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII).

Authors:  Giuseppe Sautto; Nicasio Mancini; Massimo Clementi; Roberto Burioni
Journal:  Viruses       Date:  2012-11-08       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.